Prosecution Insights
Last updated: October 04, 2026
Application No. 18/637,946

STERILE DISPOSABLE INTERFACES FOR PERCUTANEOUS INSTRUMENTS

Final Rejection §102§103
Filed
Apr 17, 2024
Priority
Apr 17, 2023 — provisional 63/459,921
Examiner
WALKER, OLIVIA
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Mendaera Inc.
OA Round
2 (Final)
36%
Grant Probability
At Risk
3-4
OA Rounds
4m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants only 36% of cases
36%
Career Allowance Rate
5 granted / 14 resolved
-34.3% vs TC avg
Strong +75% interview lift
Without
With
+75.0%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
38 currently pending
Career history
63
Total Applications
across all art units

Statute-Specific Performance

§101
10.3%
-29.7% vs TC avg
§103
50.2%
+10.2% vs TC avg
§102
16.0%
-24.0% vs TC avg
§112
22.1%
-17.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 14 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments Applicant’s arguments filed on 06/09/2026 have been fully considered but are moot in view of a new grounds of rejection. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-3, 5, and 10-12 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Wilson et al. (US 2023/0008419). In re claim 1, Wilson discloses a sterile disposable interface (FIG. 2V1-FIG. 2V3; [0118; 0120; 0121]) for percutaneous instruments [0132], the sterile disposable interface comprising: an insertion rail (306); a carriage (304, shown in greater detail in FIG. 2U1 and FIG. 2U2), wherein the carriage is attached to the insertion rail (FIG. 2V1-FIG. 2V3); a moving component (308) in proximity to the insertion rail and the carriage (FIG. 2T1); a carriage position sensor (290, shown in greater detail in FIG. 2O); and a sterile barrier (imaginary line drawn across the top of 290 in FIG. 2V1-FIG. 2V3) located between the moving component and the carriage position sensor (FIG. 2V1-FIG. 2V3; FIG. 2T1; [0121]), wherein the carriage position sensor is configured to sense, across the sterile barrier, motion of the moving component [0116; 0142], and to thereby determine a position of the carriage relative to a position of the insertion rail as the carriage moves along the insertion rail ([0116; 0142]; downward pointed arrow in FIG. 2V2 indicates movement of “carriage” along “insertion rail”). In re claim 2, Wilson discloses, further comprising an instrument adapter (FIG. 2U1: 322). In re claim 3, Wilson discloses, further comprising an instrument guide (portion of 282 that engages “instrument”, shown in greater detail in FIG. 2Q2: 286). In re claim 5, Wilson discloses, wherein the sterile disposable interface is *configured to laterally disengage (see V shape gap, 320, shown in FIG. 2U1) from a percutaneous instrument (344) at the carriage. *Examiner notes that the limitation “configured to laterally disengage from a percutaneous instrument at the carriage” comprises functional language and is given patentable weight only in how it materially alters or adds structure to the apparatus of the claims. See MPEP 2114. The prior art need only be able to perform this function in order to anticipate the claimed invention. It is clear that the system of Wilson could be operated in the claimed manner if desired. In re claim 10, Wilson discloses, wherein the sterile barrier comprises a sterile drape [0118, 0128, 0129]. In re claim 11, Wilson discloses, wherein the moving component comprises a magnet ([0142]: “encoder magnet” that is coupled to “helical screw”, i.e., [0116]: a “helical groove” (310) of “moving component” (308)) and the carriage position sensor is configured to determine the position of the carriage by sensing a magnetic field from the magnet across the sterile barrier ([0116]: apparent as encoder has a “magenetic engagement” with the “moving component” described in further detail in [0142]); In re claim 12, Wilson discloses, wherein the moving component further comprises a helical screw (310) and wherein the magnet is coupled to the helical screw ([0116; 0142]: apparent as “screw” spins the “encoder magnet”) Claim 4 is rejected under 35 U.S.C. 103 as being unpatentable over Wilson et al. (US 2023/0008419), in view of Ruiz Morales (US 2009/0024142). In re claim 4, Wilson does not disclose, further comprising a homing switch. Ruiz Morales discloses a robotic surgical system that, like Wilson, is used for performing minimally invasive surgical procedures (abstract). The robotic surgical system determines an absolute position of a slider carriage (FIG. 19: 430) through an automated homing procedure [0130]. As discussed in Ruiz Morales, the automated homing procedure is performed using a series of limit switches (426, 428). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the sterile disposable interface of Wilson to include a homing switch, as taught by Ruiz Morales. One would have been motivated to make this modification because homing is a known way to determine an absolute coordinate of a component in a robotic surgical system (Ruiz Morales, [0130]). Claims 6 and 7 are rejected under 35 U.S.C. 103 as being unpatentable over Wilson et al. (US 2023/0008419), in view of Orban III et al. (US 8,998,799). In re claim 6, Wilson does not disclose, further comprising a top lock. Orban III discloses an analogous sterile disposable interface (FIGS. 11J-11K) for percutaneous instruments (24, col. 9, lines 29-38) that comprises a carriage break (col. 11, lines 29-31). As disclosed by Orban III, the carriage break is configured to keep a carriage in a proximal position (i.e., “top”) during instrument installation (col. 11, lines 29-31). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the sterile disposable interface of Wilson to further comprise a carriage break, as taught by Orban III. One would have been motivated to make this modification because doing so would provide an operator with a way to lock/stop the carriage (Orban III, col. 11, lines 29-31). Accordingly, such a modification would yield the sterile disposable interface “further comprising a top lock”, as the carriage break functions to “lock” the carriage in a “top” position (see Orban III, col. 11, lines 29-31). In re claim 7, Wilson does not disclose, further comprising a carriage break. For substantially the same reasons as described above it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the sterile disposable interface of Wilison to further comprise a carriage break, as taught by Orban III. Claim 8 is rejected under 35 U.S.C. 103 as being unpatentable over Wilson et al. (US 2023/0008419), in view of Mishra et al. (US 2024/0173089). In re claim 8, Orban III does not disclose, further comprising a *rotation lock. Mishra discloses an analogous surgical instrument adapter (404) that attaches to a surgical guide (500). Mishra further discloses the surgical instrument adapter including a clamp (404a) that is configured to rotationally or axially lock the surgical guide in a position [0057]. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the sterile disposable interface of Wilson to further comprise a rotation lock, as taught by Mishra. One would have been motivated to make this modification to prevent the surgical guide from moving during the surgical operation (Mishra, [0047]). *As best understood, a rotation lock is being interpreted as a structure that provides resistance to rotation (instant specification, [0046]). Claim 9 is rejected under 35 U.S.C. 103 as being unpatentable Wilson et al. (US 2023/0008419), in view of Balter et al. (US 2022/0383555). In re claim 9, Wilson does not disclose, further comprising an adjustment button. Balter discloses a robotic surgical assembly (FIG. 1, FIG. 2) that like Wilson includes a rail (46a) which is configured to move a carriage (52; [0053]: “instrument drive unit”) along a longitudinal axis. The robotic surgical assembly also includes a series of buttons (FIG. 1: 53) that an operator can use to manually adjust a position of the carriage [0054]. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the sterile disposable interface of Wilson to further comprise an adjustment button, as taught by Balter. One would have been motivated to make this modification to provide the operator with a way to manually adjust the position of the carriage (Balter, [0054]). Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Contact Any inquiry concerning this communication or earlier communications from the examiner should be directed to OLIVIA WALKER whose telephone number is (571)272-7052. The examiner can normally be reached M-F: 7-4pm CT. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Hamaoui can be reached at (571)-270-5625. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /OLIVIA WALKER/Examiner, Art Unit 3796 /DAVID HAMAOUI/SPE, Art Unit 3796
Read full office action

Prosecution Timeline

Apr 17, 2024
Application Filed
Mar 09, 2026
Non-Final Rejection mailed — §102, §103
Jun 09, 2026
Response Filed
Sep 03, 2026
Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746409
LASER IRRADIATION DEVICE FOR MEDICAL TREATMENT
2y 7m to grant Granted Sep 29, 2026
Patent 12685670
LASER VITRECTOMY AND BLEEDING CESSATION TOOL
2y 5m to grant Granted Jul 21, 2026
Patent 12648822
FORCE TACTILE FEEDBACK DEVICE AT MASTER END OF ROBOT ASSISTED SYSTEM FOR VASCULAR INTERVENTIONAL SURGERY
2y 5m to grant Granted Jun 09, 2026
Study what changed to get past this examiner. Based on 3 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
36%
Grant Probability
99%
With Interview (+75.0%)
2y 9m (~4m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 14 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month